Use of the research of Apsara Biotechnology Research (“Apsara”) is at your own risk. You should do your own research and due diligence before making any investment decision with respect to securities covered herein.
You should assume that as of the publication date of any report or letter, Apsara and our clients, analysts and/or contributors have a long or short position in the stocks covered herein. If the report discusses a given stock as being overvalued and has a negative sentiment towards the stock, you should assume that Apsara has a short position in the stock covered, or otherwise benefits in the event of a price decline. If the report discusses a given stock as being undervalued and has a positive sentiment towards the stock, you should assume that Apsara has a long position in the stock covered, or otherwise benefits in the event of a price increase. Following publication of any report or letter, we intend to continue transacting in the securities of stock covered therein, and we may be long, short, or neutral at any time hereafter regardless of our initial recommendation.
This is not an offer to sell or a solicitation of an offer to buy any security, nor shall any security be offered or sold to any person, in any jurisdiction in which such offer would be unlawful under the securities laws of such jurisdiction. Apsara is not registered as an investment advisor. To the best of our ability and belief, all information contained herein is accurate and reliable, and has been obtained from public sources we believe to be accurate and reliable, and who are not insiders or connected persons of the stock covered herein or who may otherwise owe any fiduciary duty or duty of confidentiality to the issuer. However, such information is presented “as is,” without warranty of any kind – whether express or implied. Apsara makes no representation, express or implied, as to the accuracy, timeliness, or completeness of any such information or with regard to the results to be obtained from its use. All expressions of opinion are subject to change without notice, and Apsara does not undertake to update or supplement this report or any of the information contained herein.
The failure of Apsara to exercise or enforce any right or provision of these Terms of Service shall not constitute a waiver of this right or provision. If any provision of these Terms of Service is found by a court of competent jurisdiction to be invalid, the parties nevertheless agree that the court should endeavor to give effect to the parties’ intentions as reflected in the provision and rule that the other provisions of these Terms of Service remain in full force and effect, in particular as to this governing law and jurisdiction provision. You agree that regardless of any statute or law to the contrary, any claim or cause of action arising out of or related to use of this website or the material herein must be filed within one (1) year after such claim or cause of action arose or be forever barred.